Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Hepatitis B Virus (HBV) Immunity and Hepatitis B Vaccination in Patients With Non Alcoholic Fatty Liver Disease (NAFLD) in Canada

NCT02985450 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT02985450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02985450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Hepatitis B Virus (HBV) Immunity and Hepatitis B Vaccination in Patients With Non Alcoholic Fatty Liver Disease (NAFLD) in Canada
Lead sponsor
University of Calgary
Phase
Observational
Overall status
Completed
Start date
August 31, 2016
Completion date
January 31, 2021
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, non-alcoholic fatty liver disease, vaccine reaction